Anti-Leukemic Effects Induced by Dendritic Cells of Leukemic Origin from Leukemic Blood Samples Are Comparable under Hypoxic vs. Normoxic Conditions.
Fatemeh Doraneh-GardDaniel Christoph AmbergerCarina AmendMelanie WeinmannChristoph SchwepckeLara Kristina KlauerOlga SchuttiHedayatollah HosseiniDoris KrämerAndreas RankChristoph SchmidHelga Maria SchmetzerPublished in: Cancers (2024)
Hypoxia can modulate the immune system by affecting the function and activity of immune cells, potentially leading to altered immune responses. This study investigated the generation of leukemia-derived dendritic cells (DC leu) from leukemic blasts and their impact on immune cell activation under hypoxic (5-10% O 2 ) compared to normoxic (21% O 2 ) conditions using various immunomodulatory Kits. The results revealed that DC/DC leu -generation was similar under hypoxic and normoxic conditions, with no significant differences observed in frequencies of generated DC/DC leu . Furthermore, the study showed that the activation of immune cells and their anti-leukemic activity improved when T cell-enriched immunoreactive cells were co-cultured with DC/DC leu which were generated with Kit I and M compared to the control after mixed lymphocyte cultures. The anti-leukemic activity was improved under hypoxic compared to normoxic conditions after MLC WB-DC Kit M . These findings suggest that DC/DC leu -cultures of leukemic whole blood with Kits under hypoxic conditions yield comparable frequencies of DC/DC leu and can even increase the anti-leukemic activity compared to normoxic conditions. Overall, this research highlights the potential of utilizing DC/DC leu (potentially induced in vivo with Kits) as a promising approach to enhance immune response in patients with acute myeloid leukemia.